US Patent Issued to Protean Bio, University of New South Wales on Aug. 4 for "Peptides for beta-cell survival and insulin production" (Australian, American Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,319, issued on Aug. 4, was assigned to Protean Bio Inc. and University of New South Wales (Sydney).

"Peptides for beta-cell survival and insulin production" was invented by Kerry-Anne Rye (Sydney), Madhav Devalaraja (Lexington, Mass.), Mate Biro (Sydney), Blake Cochran (Sydney), Thomas King (Sydney), Szun Tay (Sydney), Feyza Colakoglu (Sydney) and Vanesaa Prajitno (Sydney).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method to prevent a disease, comprising: (1) administering a peptide comprising Delta6PV into a subject comprising a human or an animal; wherein the disease comprises one of more of Type 1 diabetes, rheumatoid arthritis, lupus, Sjogre...